Treatment of Multiple Sclerosis with Anti-CD52 Antibodies
- 专利权人:
- GENZYME CORPORATION
- 发明人:
- David H. MARGOLIN
- 申请号：
- US16606622
- 公开号：
- US20200299399A1
- 申请日:
- 2018.04.20
- 申请国别(地区):
- US
- 年份:
- 2020
- 代理人:
- 摘要：
- The present invention relates to treatment of relapsing and progressive forms of multiple sclerosis using a humanized anti-human CD52 IgG1 monoclonal antibody.
- 来源网站：
- 中国工程科技知识中心
